Conference Paper: CRIP2 is a candidate tumor suppressor in nasopharyngeal carcinoma associated with in vivo tumor suppression and angiogenesis inhibition.

File Download
Supplementary
  • Basic View
  • Metadata View
  • XML View
TitleCRIP2 is a candidate tumor suppressor in nasopharyngeal carcinoma associated with in vivo tumor suppression and angiogenesis inhibition.
AuthorsCheung, AKL
Ko, JMY
Lung, HL
Chan, KW
Stanbridge, EJ
Zabarovsky, ER
Kwong, DLW
Chua, DTT
Tsao, GSW
Lung, ML
Issue Date2010
CitationThe 17th Hong Kong International Cancer Congress [How to Cite?]
DC Field
Value
dc.contributor.authorCheung, AKL
dc.contributor.authorKo, JMY
dc.contributor.authorLung, HL
dc.contributor.authorChan, KW
dc.contributor.authorStanbridge, EJ
dc.contributor.authorZabarovsky, ER
dc.contributor.authorKwong, DLW
dc.contributor.authorChua, DTT
dc.contributor.authorTsao, GSW
dc.contributor.authorLung, ML
dc.date.accessioned2011-09-23T06:05:25Z
dc.date.available2011-09-23T06:05:25Z
dc.date.issued2010
dc.identifier.citationThe 17th Hong Kong International Cancer Congress [How to Cite?]
dc.identifier.hkuros194821
dc.identifier.urihttp://hdl.handle.net/10722/140040
dc.languageeng
dc.relation.ispartofThe 17th Hong Kong International Cancer Congress
dc.titleCRIP2 is a candidate tumor suppressor in nasopharyngeal carcinoma associated with in vivo tumor suppression and angiogenesis inhibition.
dc.typeConference_Paper